$SFES
SAFEGUARD SCIENTIFICS INC

2021 Q4 Form 10-Q Financial Statement

#000143774921025316 Filed on November 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin -$65.00K $1.564M $1.200M
YoY Change -105.42% -25.52% -42.86%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses -$65.00K $1.564M $1.200M
YoY Change -105.42% -25.52% -42.86%
Operating Profit -$1.135M -$1.564M -$1.631M
YoY Change -30.41% -31.25% -20.83%
Interest Expense -$1.507M -$691.0K -$3.000M
YoY Change -49.77% -42.42% 233.33%
% of Operating Profit
Other Income/Expense, Net -$5.992M $20.59M -$663.0K
YoY Change 803.77% -2610.73% -129.53%
Pretax Income -$8.634M $18.33M -$7.353M
YoY Change 17.42% -522.13% 953.44%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$8.634M $18.33M -$7.353M
YoY Change 17.42% -522.13% 953.44%
Net Earnings / Revenue
Basic Earnings Per Share -$0.51 $0.88 -$0.35
Diluted Earnings Per Share -$0.51 $0.88 -$0.35
COMMON SHARES
Basic Shares Outstanding 16.51M 20.79M 20.89M
Diluted Shares Outstanding 20.79M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $24.74M $64.21M $15.60M
YoY Change 58.58% 291.53% -37.6%
Cash & Equivalents $24.74M $64.20M $15.60M
Short-Term Investments $4.549M $10.80M
Other Short-Term Assets $5.539M $12.16M $500.0K
YoY Change 1007.8% 1926.67% -61.54%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $30.28M $76.37M $16.06M
YoY Change 88.5% 349.06% -39.04%
LONG-TERM ASSETS
Property, Plant & Equipment $1.561M $1.622M $1.790M
YoY Change -12.79% -13.22% -14.8%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $21.21M $23.95M $27.82M
YoY Change -23.77% -22.02% -19.46%
Other Assets $217.0K $233.0K $784.0K
YoY Change -72.32% -82.97% -60.74%
Total Long-Term Assets $23.75M $27.35M $52.97M
YoY Change -55.16% -53.71% -34.79%
TOTAL ASSETS
Total Short-Term Assets $30.28M $76.37M $16.06M
Total Long-Term Assets $23.75M $27.35M $52.97M
Total Assets $54.03M $103.7M $69.04M
YoY Change -21.74% 36.31% -35.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $41.00K $77.00K $56.00K
YoY Change -26.79% 113.89% 43.59%
Accrued Expenses $524.0K $643.0K $410.0K
YoY Change 27.8% 21.09% -34.61%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.734M $3.899M $3.470M
YoY Change -50.03% 49.33% 42.86%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $50.00K $50.00K $637.0K
YoY Change -92.15% -95.49% -37.97%
Total Long-Term Liabilities $50.00K $50.00K $637.0K
YoY Change -92.15% -95.49% -37.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.734M $3.899M $3.470M
Total Long-Term Liabilities $50.00K $50.00K $637.0K
Total Liabilities $3.462M $5.725M $6.160M
YoY Change -43.8% -2.29% 5.55%
SHAREHOLDERS EQUITY
Retained Earnings -$709.6M -$701.0M -$736.6M
YoY Change -3.67% -3.88% 5.65%
Common Stock $808.8M $808.7M $809.7M
YoY Change -0.12% -0.33% -0.4%
Preferred Stock
YoY Change
Treasury Stock (at cost) $48.57M $9.688M $10.20M
YoY Change 376.17% -17.94% -27.27%
Treasury Stock Shares $5.068M $777.0K $688.0K
Shareholders Equity $50.57M $97.99M $62.90M
YoY Change
Total Liabilities & Shareholders Equity $54.03M $103.7M $69.04M
YoY Change -21.74% 36.31% -35.83%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q4
OPERATING ACTIVITIES
Net Income -$8.634M $18.33M -$7.353M
YoY Change 17.42% -522.13% 953.44%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$2.708M -$710.0K -$1.100M
YoY Change 146.18% -40.83% -26.67%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $2.273M $43.69M $300.0K
YoY Change 657.67% 992.25% -81.25%
Cash From Investing Activities $2.273M $43.69M $300.0K
YoY Change 657.67% 992.25% -81.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -39.04M -74.00K 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -2.708M -710.0K -1.100M
Cash From Investing Activities 2.273M 43.69M 300.0K
Cash From Financing Activities -39.04M -74.00K 0.000
Net Change In Cash -39.47M 42.91M -800.0K
YoY Change 4834.0% 1432.36% -96.12%
FREE CASH FLOW
Cash From Operating Activities -$2.708M -$710.0K -$1.100M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
83333000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
83333000
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16505594
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21573000
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21573000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21573000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21573000
CY2021Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
777000
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
688000
CY2021Q3 sfe Impairment Of Other Method Securities
ImpairmentOfOtherMethodSecurities
2500000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64211000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15601000 USD
CY2021Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
25000 USD
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 USD
CY2021Q3 us-gaap Trading Securities
TradingSecurities
10792000 USD
CY2020Q4 us-gaap Trading Securities
TradingSecurities
0 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1343000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
462000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
76371000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
16063000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1622000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1790000 USD
CY2021Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
25492000 USD
CY2020Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
50398000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
233000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
784000 USD
CY2021Q3 us-gaap Assets
Assets
103718000 USD
CY2020Q4 us-gaap Assets
Assets
69035000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
77000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
56000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2817000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2677000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
643000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
410000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
362000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
327000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3899000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3470000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1776000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2053000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
50000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
637000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
5725000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
6160000 USD
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
2157000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2157000 USD
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
806550000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
807582000 USD
CY2021Q3 us-gaap Treasury Stock Value
TreasuryStockValue
9688000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
10200000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-701001000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-736639000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-25000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-25000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
97993000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
62875000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
103718000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
69035000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1564000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2275000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6018000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7835000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1564000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2275000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-6018000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-7835000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20588000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-820000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
28027000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7045000 USD
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
70000 USD
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
52000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
197000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
209000 USD
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-761000 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1300000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
13432000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-15591000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18333000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4343000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
35638000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30262000 USD
CY2021Q3 us-gaap Profit Loss
ProfitLoss
18333000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-4343000 USD
us-gaap Profit Loss
ProfitLoss
35638000 USD
us-gaap Profit Loss
ProfitLoss
-30262000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.88
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.71
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.46
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.88
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.71
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.46
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20786000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20786000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20847000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20731000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20786000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20786000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20847000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20731000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5444000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7025000 USD
us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
58559000 USD
us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
7587000 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
-0 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
7510000 USD
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
2718000 USD
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
1638000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
55841000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1561000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1639000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-0 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
123000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
30000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1762000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-30000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
48635000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-8616000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15601000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25053000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64236000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16437000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
62875000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
17625000 USD
CY2021Q1 sfe Stock Issued During Period Value Restricted Stock Award Withheld For Taxes
StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes
370000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
122000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
80992000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-320000 USD
CY2021Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1588000 USD
CY2021Q2 sfe Stock Issued During Period Value Restricted Stock Award Withheld For Taxes
StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes
137000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
175000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
79396000 USD
CY2021Q3 us-gaap Profit Loss
ProfitLoss
18333000 USD
CY2021Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
51000 USD
CY2021Q3 sfe Stock Issued During Period Value Restricted Stock Award Withheld For Taxes
StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes
114000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
201000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
97993000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
101741000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-16008000 USD
CY2020Q1 sfe Stock Issued During Period Value Restricted Stock Award Withheld For Taxes
StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes
72000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
85808000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-9911000 USD
CY2020Q2 sfe Stock Issued During Period Value Restricted Stock Award Withheld For Taxes
StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes
72000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
146000 USD
CY2020Q2 sfe Cumulative Effect Of Change In Accounting At Ownership Interests
CumulativeEffectOfChangeInAccountingAtOwnershipInterests
-1801000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
74314000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-4343000 USD
CY2020Q3 sfe Stock Issued During Period Value Restricted Stock Award Withheld For Taxes
StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes
73000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
185000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
70229000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64200000 USD
CY2021Q3 us-gaap Equity Method Investments
EquityMethodInvestments
23945000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
27821000 USD
CY2021Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
11564000 USD
CY2020Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
19951000 USD
CY2021Q3 us-gaap Advances To Affiliate
AdvancesToAffiliate
775000 USD
CY2020Q4 us-gaap Advances To Affiliate
AdvancesToAffiliate
2626000 USD
CY2021Q3 sfe Investments And Advances To Affiliates Current And Noncurrent
InvestmentsAndAdvancesToAffiliatesCurrentAndNoncurrent
36284000 USD
CY2020Q4 sfe Investments And Advances To Affiliates Current And Noncurrent
InvestmentsAndAdvancesToAffiliatesCurrentAndNoncurrent
50398000 USD
sfe Impairment Of Other Method Securities
ImpairmentOfOtherMethodSecurities
2500000 USD
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
484000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
452000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1469000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
979000 USD
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20786000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20847000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20731000
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.88
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.71
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q3 us-gaap Profit Loss
ProfitLoss
18333000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-4343000 USD
us-gaap Profit Loss
ProfitLoss
35638000 USD
us-gaap Profit Loss
ProfitLoss
-30262000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20786000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20786000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20847000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20731000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.88
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.71
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.46
CY2021Q3 us-gaap Profit Loss
ProfitLoss
18333000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-4343000 USD
us-gaap Profit Loss
ProfitLoss
35638000 USD
us-gaap Profit Loss
ProfitLoss
-30262000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20786000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20786000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20847000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20731000
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2020Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2021Q3 us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
0
CY2020Q3 us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
0
us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
0
us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
0
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20786000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.46
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
149000 USD
CY2021Q3 sfe Lessee Subleaseexpected Receipts Remainder Of Fiscal Year
LesseeSubleaseexpectedReceiptsRemainderOfFiscalYear
132000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
601000 USD
CY2021Q3 sfe Lessee Sublease Expected Receipts Year One
LesseeSubleaseExpectedReceiptsYearOne
540000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
607000 USD
CY2021Q3 sfe Lessee Subleaseexpected Receipts Year Two
LesseeSubleaseexpectedReceiptsYearTwo
556000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
613000 USD
CY2021Q3 sfe Lessee Subleaseexpected Receipts Year Three
LesseeSubleaseexpectedReceiptsYearThree
573000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
619000 USD
CY2021Q3 sfe Lessee Subleaseexpected Receipts Year Four
LesseeSubleaseexpectedReceiptsYearFour
590000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
207000 USD
CY2021Q3 sfe Lessee Subleaseexpected Receipts Year Five
LesseeSubleaseexpectedReceiptsYearFive
199000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2796000 USD
CY2021Q3 sfe Lessee Sublease Expected Receipts Total
LesseeSubleaseExpectedReceiptsTotal
2590000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
658000 USD
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2138000 USD
sfe Long Term Incentive Plan Payments
LongTermIncentivePlanPayments
400000 USD
CY2021Q3 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
2100000 USD
CY2021Q3 us-gaap Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
100000 USD
CY2021Q2 us-gaap Payments For Postemployment Benefits
PaymentsForPostemploymentBenefits
400000 USD
CY2021Q3 sfe Employee And Severance Agreement Maximum Aggregate Exposure
EmployeeAndSeveranceAgreementMaximumAggregateExposure
600000 USD

Files In Submission

Name View Source Status
0001437749-21-025316-index-headers.html Edgar Link pending
0001437749-21-025316-index.html Edgar Link pending
0001437749-21-025316.txt Edgar Link pending
0001437749-21-025316-xbrl.zip Edgar Link pending
ex_277656.htm Edgar Link pending
ex_277657.htm Edgar Link pending
ex_277658.htm Edgar Link pending
ex_277659.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sfe-20210930.xsd Edgar Link pending
sfe-20210930_cal.xml Edgar Link unprocessable
sfe-20210930_def.xml Edgar Link unprocessable
sfe-20210930_lab.xml Edgar Link unprocessable
sfe-20210930_pre.xml Edgar Link unprocessable
sfe20210930_10q.htm Edgar Link pending
sfe20210930_10q_htm.xml Edgar Link completed
Show.js Edgar Link pending